Procedural and surgical treatment modalities for acne scarring: Part II - 14/05/24

Doi : 10.1016/j.jaad.2022.04.022

Michael Renzi, MD, Matt McLarney, MD, Tara Jennings, MD ^⁎ , Robert Duffy, MD, Warren R. Heymann, MD, Naomi Lawrence, MD, Ashley Decker, MD
Cooper University Hospital and Cooper Medical School of Rowan University, Camden, New Jersey

^∗Correspondence to: Tara Jennings, MD, Department of Dermatology and Dermatologic Surgery, Cooper University Hospital, Cooper University Health Care Dermatology 3 Cooper Plaza, Suite 504, Camden, NJ 08103.Department of Dermatology and Dermatologic SurgeryCooper University HospitalCooper University Health Care Dermatology 3 Cooper PlazaSuite 504CamdenNJ08103

Abstract

The optimal treatment of acne scarring is challenging because several factors need to be considered, including the type and number of scars, Fitzpatrick skin type, and the amount of downtime permissible to the patient. This second article in the continuing medical education series discusses the procedural treatments available for acne scarring, including the use of chemical peels, fillers, radiofrequency microneedling, lasers, and surgical procedures. The indications for each modality, evidence for its benefits, and the adverse effects are discussed. This section aims to help guide the reader select and implement the most appropriate treatment based on the patient's preferences, acne scarring, and skin type.

Le texte complet de cet article est disponible en PDF.

Key words : chemical peels, fillers, laser, punch elevation, punch excision, radiofrequency microneedling, subcision, TCA-CROSS

Abbreviations used : CaHA, CROSS, Er:YAG, FACO₂, GA, PLLA, PMMA, PRP, SA, TCA

Plan

	Funding sources: None.
	IRB approval status: Not applicable.
	Patient Consent on File: Written consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and attested to at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available.
	Date of release: June 2024.
	Expiration date: June 2027.